E. Márquez Martín (Sevilla, Spain), A. Nyberg (Umeå, Sweden), F. Schleich (Liège, Belgium), N. Toledo Pons (Palma De Mallorca, Spain)
Longitudinal study of CAT in a COPD cohort and its relationship with change in patient's impression of disease severity. Preliminary data.
E. Buonamico (Bari, Italy), V. Liotino (Bari, Italy), M. Vulpi (Bari, Italy), M. Dimitri (Bari, Italy), A. Capozzolo (Cassano delle Murge, Italy), S. Dragonieri (Bari, Italy), O. Resta (Bari, Italy)
|   |
EXACT-PRO correlates with FEV1 and systemic inflammation but not airway inflammation
A. Yousuf (Leicester, United Kingdom), G. Parekh (Bedford, United Kingdom), S. Parker (Leicester, United Kingdom), S. Glover (Leicester, United Kingdom), J. Finch (Leicester, United Kingdom), L. Carr (Leicester, United Kingdom), V. Mistry (Leicester, United Kingdom), A. Duvoix (Bedford, United Kingdom), L. O'Brien (Cardiff, United Kingdom), K. Lewis (Swansea, United Kingdom), C. Brightling (Leicester, United Kingdom)
| |
Features of COPD in correlation with COPD assessment test
L. Boussoffara (Mahdia, Tunisia), I. Touil (Mahdia, Tunisia), S. Bouchareb (Mahdia, Tunisia), N. Boudawara (Mahdia, Tunisia), A. Msakni (Mahdia, Tunisia), J. Knani (Mahdia, Tunisia)
| |
Benefits of long-term oxygen therapy among COPD patients with moderate resting desaturation
A. Ben Saad (Monastir, Tunisia), A. Migaou (Monastir, Tunisia), N. Fahem (Monastir, Tunisia), S. Cheikh Mhamed (Monastir, Tunisia), S. Joobeur (Monastir, Tunisia), N. Rouatbi (Monastir, Tunisia)
| |
Clinical characteristics of COPD and resources in general and specialized COPD outpatient respiratory clinics.
G. Vargas Centanaro (Madrid, Spain), M. Calle Rubio (Madrid, Spain), E. Forcen Vicente De Vera (Madrid, Spain), M. Bernabe Barrios (Madrid, Spain), S. Smaili (Madrid, Spain), D. Sesma Gonzalez (Madrid, Spain), J. Rodriguez Hermosa (Madrid, Spain)
| |
Clinical prediction guides in COPD, a real life evaluation
M. Barata (Almada, Portugal), R. Gomes (Almada, Portugal), J. Portela (Almada, Portugal), H. Grumete (Almada, Portugal), F. Menezes (Almada, Portugal), J. Duarte (Almada, Portugal)
| |
Burden and drivers of severe hypoxemia in real life patients with stable COPD
G. Deslee (Reims , France), T. Perez (Lille, France), P. Burgel (Paris Cochin, France), M. Zysman (Créteil, France), O. Le Rouzic (Lille, France), G. Brinchault-Rabin (Rennes, France), P. Nesme-Meyer (Lyon, France), I. Court-Fortune (Saint Etienne, France), G. Jebrak (Paris Bichat, France), P. Chanez (Marseille, France), D. Caillaud (Clermont Ferrand, France), J. Paillasseur (Paris, France), N. Roche (Paris Cochin, France)
| |
Daily symptom variability in patients with stable COPD in Brazil
M. Penha (São Paulo, Brazil), A. Menezes (Pelotas, Brazil), I. Godoy (Botucatu, Brazil), C. Costa (Rio de Janeiro, Brazil), A. Rubin (Porto Alegre, Brazil), M. Gregorio (São Paulo, Brazil), M. Lima (Blumenau, Brazil), A. Albuquerque Neto (São Paulo, Brazil), M. Pereira (Campinas, Brazil), S. Tanni (Botucatu, Brazil), R. Athanazio (São Paulo, Brazil), E. Bessa (Rio de Janeiro, Brazil), F. Wehrmeister (Pelotas, Brazil), C. Lourenco (Santo Andre, Brazil), A. Cukier (São Paulo, Brazil)
| |
Home management of severe Chronic Obstructive Pulmonary Disease (COPD): results from a randomized controlled study in Italy
M. Roggi (Pisa, Italy), V. Lorenzoni (Pisa, Italy), R. Vargiu (Pisa, Italy), G. Corona (Pisa, Italy), I. Palla (Pisa, Italy), S. Santerini (Pisa, Italy), M. Bartoli (Pisa, Italy), B. Vagaggini (Pisa, Italy), G. Turchetti (Pisa, Italy), P. Paggiaro (Pisa, Italy)
| |
The use of Prevexair application in patients with COPD.
S. Esmaili (Madrid, Spain), J. Rodriguez Hermosa (Madrid, Spain), A. Fuster Gomila (Madrid, Spain), L. Puente Maestu (Madrid, Spain), C. Amado Diago (Madrid, Spain), F. Callejas González (Madrid, Spain), R. Malo De Molina Ruiz (Madrid, Spain), A. Montero Pacios (Madrid, Spain), M. Calle Rubio (Madrid, Spain)
| |
The validation of the COPD screening questionnaires and establishment for the detection of COPD subjects in the general medical check-up setting.
M. Hanibuchi (Shikoku-Chuo, Japan), Y. Ishimura (Shikoku-Chuo, Japan), S. Hamada (Shikoku-Chuo, Japan), A. Saijo (Shikoku-Chuo, Japan)
| |
Exercise capacity in chronic obstructive pulmonary disease: Cardiopulmonary exercise testing versus 6-minute walk test
J. Neiva Machado (Coimbra, Portugal), J. Coutinho Costa (Coimbra, Portugal), T. Costa (Coimbra, Portugal), C. Rodrigues (Coimbra, Portugal)
| |
Correlation of obstructive pulmonary disease assessement test with spirometric estimated lung age in tunisian patients of stable chronic obstructive pulmonay disease
K. Kchaou (Sfax, Tunisia), R. Kammoun (Sfax, Tunisia), M. Chaabouni (Sfax, Tunisia), A. Haddar (Sfax, Tunisia), L. Triki (Sfax, Tunisia), I. Kammoun (Sfax, Tunisia), H. Zouari (Sfax, Tunisia), K. Masmoudi (Sfax, Tunisia)
| |
Agreement Between COPD Assessment Test (CAT) And Modified Medical Research Council (mMRC) Dyspnea Scores For GOLD COPD Classification: A Cross-Sectional Analyses
M. Montes De Oca (Caracas, Venezuela), A. Menezes (Pelotas, Brazil), F. Wehrmeister (PelotasaracSan Jose, Brazil), V. Lopez (Montevideo, Uruguay), L. Ramirez (San Jose, Costa Rica), M. Miratvilles (Barcelona, Spain)
| |
HAND GRIP STRENGHT AND CAT SCORE IN COPD
E. Baran (La Plata, Argentina)
| |
COPD Assessment Test (CAT) has a positive relationship with exacerbations in COPD patients.
S. Min (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea), Y. Park (Seoul, Republic of Korea), H. Yum (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), J. Yoo (Seoul, Republic of Korea)
| |
Muscle ultrasound measurements in COPD patients
F. Chermiti Ben Abdallah (Ariana, Tunisia), I. Bachouch (Ariana, Tunisia), N. Belloumi (Ariana, Tunisia), H. Neji (Ariana, Tunisia), S. Fenniche (Ariana, Tunisia)
| |
Factors affecting the development of airflow limitation among cigarette smokers
W. Cho (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea)
| |